We are live on ! Find out more
Jefferies Group

Jefferies Group Portfolio holdings

AUM $12B Turnover 50.93%
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
–
AUM
$12B
AUM Growth
-$88.4M
Cap. Flow
-$422M
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.99%
Holding
2,099
New
574
Increased
345
Reduced
315
Closed
495
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
1.3 years
Top 20 Avg Time Held Equity + Options
1.1 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.7 years
Top 20 Avg Time Held Equity only
0.5 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.96%
2 Healthcare 3.52%
3 Technology 2.98%
4 Consumer Discretionary 2.78%
5 Industrials 2.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ASO icon
1476
Academy Sports + Outdoors
ASO
$3.72B
– –
-8,600
Closed -$306K –
LONA icon
1477
CALL
LeonaBio Inc
LONA
$45.6M
– –
-9,290
Closed -$283K –
LONA icon
1478
LeonaBio Inc
LONA
$45.6M
– –
-20,126
Closed -$614K –
LONA icon
1479
PUT
LeonaBio Inc
LONA
$45.6M
– –
-18,130
Closed -$553K –
ATRA icon
1480
Atara Biotherapeutics
ATRA
$86.2M
– –
-2,800
Closed -$545K –
AU icon
1481
AngloGold Ashanti
AU
$42.3B
– –
-60,000
Closed -$855K –
AUR icon
1482
Aurora
AUR
$9.6B
– –
-48,937
Closed -$93.5K –
AVTR icon
1483
Avantor
AVTR
$11.7B
– –
-27,161
Closed -$845K –
AVXL icon
1484
Anavex Life Sciences
AVXL
$123M
– –
-3,403
Closed -$35.9K –
AXTA icon
1485
Axalta
AXTA
$7.31B
– –
-9,683
Closed -$214K –
BBWI icon
1486
CALL
Bath & Body Works
BBWI
$4.22B
– –
-375,000
Closed -$10.1M –
BBWI icon
1487
PUT
Bath & Body Works
BBWI
$4.22B
– –
-276,000
Closed -$7.43M –
BCO icon
1488
Brink's
BCO
$4.58B
– –
-5,110
Closed -$310K –
BCRX icon
1489
CALL
BioCryst Pharmaceuticals
BCRX
$1.95B
– –
-200,000
Closed -$2.12M –
BCRX icon
1490
BioCryst Pharmaceuticals
BCRX
$1.95B
– –
-76,100
Closed -$805K –
BCRX icon
1491
PUT
BioCryst Pharmaceuticals
BCRX
$1.95B
– –
-100,000
Closed -$1.06M –
BEAM icon
1492
Beam Therapeutics
BEAM
$2.48B
– –
-8,897
Closed -$344K –
BEKE icon
1493
KE Holdings
BEKE
$18.8B
– –
-25,000
Closed -$449K –
BFH icon
1494
Bread Financial
BFH
$3.84B
– –
-7,235
Closed -$268K –
BILL icon
1495
BILL Holdings
BILL
$4.32B
– –
-4,724
Closed -$519K –
BIO icon
1496
Bio-Rad Laboratories Class A
BIO
$9.9B
– –
-417
Closed -$206K –
BIRD icon
1497
Smartbird Inc
BIRD
$27M
– –
-528
Closed -$41.5K –
BNY icon
1498
Bank of New York Mellon
BNY
$98.6B
– –
-26,911
Closed -$1.12M –
BL icon
1499
CALL
BlackLine
BL
$2.02B
– –
-70,000
Closed -$4.66M –
BL icon
1500
BlackLine
BL
$2.02B
– –
-20,250
Closed -$1.35M –

Similar funds

Jefferies Group's Q3 2022 Portfolio in Review

As of Q3 2022, Jefferies Group held 2,099 positions worth $12B, down 0.73% from $12B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Jefferies Group withdrew a net $422M in Q3 2022, closing 495 positions and reducing 315 holdings. Its most notable exit was Avis, an estimated $248M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, down from 81% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Jefferies Group opened a new position in State Street SPDR Bloomberg Short Term High Yield Bond ETF worth $28.6M.

  • Jefferies Group's largest Q3 2022 buy was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 1,200,777 shares worth $28.6M.
  • Jefferies Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $73.8M increase.
  • Jefferies Group's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $105M.
  • Jefferies Group fully exited Avis in Q3 2022, selling an estimated $248M.
  • Jefferies Group's ten largest holdings make up 33% of its $12B portfolio in Q3 2022.
  • Jefferies Group opened 574 new positions and closed 495 in Q3 2022.
  • Jefferies Group's portfolio value fell 0.73% quarter-over-quarter to $12B.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.